Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 16;12(6):790.
doi: 10.3390/brainsci12060790.

Vitamin D Status and Parkinson's Disease

Affiliations
Review

Vitamin D Status and Parkinson's Disease

Michela Barichella et al. Brain Sci. .

Abstract

Parkinson's disease (PD) is a complex and progressive neurodegenerative disease, characterized by resting tremor, rigidity, slowness of movement, and postural instability. Furthermore, PD is associated with a wide spectrum of non-motor symptoms that add to overall disability. In recent years, some investigations, from basic science to clinical applications, have focused on the role of vitamin D in PD, often with controversial findings. Vitamin D has widespread effects on several biological processes in the central nervous system, including neurotransmission in dopaminergic neural circuits. Various studies have recorded lower levels of vitamin D in PD patients than in healthy controls. Low vitamin D status has also been correlated with the risk for PD and motor severity, whereas less is known about the effects vitamin D has on cognitive function and other non-motor symptoms. This review aims to better characterize the correlation between vitamin D and PD, clarify the role of vitamin D in PD prevention and treatment, and discuss avenues for future research in this field.

Keywords: Parkinson’s disease; hypovitaminosis D; vitamin D; vitamin D deficiency; vitamin D insufficiency; vitamin D receptor (VDR) polymorphisms.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Bloem B.R., Okun M.S., Klein C. Parkinson’s disease. Lancet. 2021;397:2284–2303. doi: 10.1016/S0140-6736(21)00218-X. - DOI - PubMed
    1. Tolosa E., Garrido A., Scholz S.W., Poewe W. Challenges in the diagnosis of Parkinson’s disease. Lancet Neurol. 2021;20:385–397. doi: 10.1016/S1474-4422(21)00030-2. - DOI - PMC - PubMed
    1. Poewe W., Seppi K., Tanner C.M., Halliday G.M., Brundin P., Volkmann J., Schrag A.E., Lang A.E. Parkinson disease. Nat. Rev. Dis. Primers. 2017;3:17013. doi: 10.1038/nrdp.2017.13. - DOI - PubMed
    1. Plum L.A., DeLuca H.F. Vitamin D, disease and therapeutic opportunities. Nat. Rev. Drug Discov. 2010;9:941–955. doi: 10.1038/nrd3318. - DOI - PubMed
    1. Pilz S., Zittermann A., Trummer C., Theiler-Schwetz V., Lerchbaum E., Keppel M.H., Grübler M.R., März W., Pandis M. Vitamin D testing and treatment: A narrative review of current evidence. Endocr. Connect. 2019;8:R27–R43. doi: 10.1530/EC-18-0432. - DOI - PMC - PubMed